Wednesday, 30 November 2011

Nimesulide side effects


Nimesulide side effects

occasionally they can include fever, nausea, upper abdominal pain and headaches, transitórias. A generally mild and similar to other nonsteroidal anti-inflammatory drugs, the drug may cause drowsiness and dizziness. Were observed, rarely, skin rashes, allergic type.

Nimesulide dosage

It is advisable to Nimesulide administered after meals. In cases of renal impairment, dosage should be adapted to the needs of each patient, according to the values ​​of glomerular filtration.

Nimesulide drops are particularly suitable for pediatric use, it enables a dosage adapted to each case, according to body weight of the child and within the recommended dosage schedule for children.
Every drop of the product contains 2.5 mg of nimesulide.

Children over one year:
The recommended dosage is 5 mg / kg / day, divided the medical criteria in two administrations. It is recommended to administer one drop per kg of body weight twice a day directly into the mouth of the child or if you prefer, diluted in a little sugar water.

The bottle should be shaken before administering the drops.

Overdosage: - NIMESULIDE

So far there have been no cases of overdose with the product. In case of overdose with the product, it is recommended induction of emesis or aspiration and lavage. If poisoning occurs, it may be necessary if alkaline diuresis and renal function impairment may be necessary to perform a hemodialysis.

ELDERLY PATIENTS: - NIMESULIDE


Clinical studies in the elderly have indicated the need to change the normal dose. However, because elderly patients may be more susceptible to adverse effects, a reduced dose may be appropriate in individual cases.

Use in pregnancy and lactation- Nimesulide


As with other nonsteroidal anti-inflammatory drugs (NSAIDs), use during pregnancy is not recommended.
The use of NSAIDs by the end of pregnancy is associated with a higher incidence of dystocia and uterine atony. NSAIDs are also associated with the induction of the closure of the ductus arteriosus. So far no information is available on the excretion of nimesulide in human milk and therefore it should not be administered to women who are breastfeeding.


0 comments:

Post a Comment